Target intelligence / Profile preview

Septin 14 pseudogene 21 (SEPTIN14P21)

Target
SEPTIN14P21
Molecular classification
Other (Pseudogene)
01

Overview

Septin 14 pseudogene 21 is a genomic region closely resembling the functional gene *Septin 14*, but with disabling mutations (such as frameshifts, premature stop codons, or missing regulatory elements) that prevent its transcription and translation into a functional protein[2][3][4]. Pseudogenes like SEPTIN14P21 may occasionally be transcribed into RNA and, in rare cases, participate in regulation of their parent genes or related pathways, but most are nonfunctional and considered "junk DNA"[1][3][4]. In general, pseudogenes complicate molecular genetic analyses due to their sequence similarity to functional genes, which can cause technical artifacts but do not themselves represent therapeutic targets[4]. There is no evidence SEPTIN14P21 acts as a receptor, enzyme, or other classical drug target, and no data supporting its role in disease or drug interaction. It is best classified simply as a pseudogene[2][3][4].

Other names
SEPT14P21
02

Mechanism of action

None (No mechanisms of action are described because it lacks protein-coding ability[3][4])

03

Biological functions

Potential regulatory RNA function (Very few pseudogenes have documented biological roles, occasionally as competing endogenous RNAs or microRNA decoys[1][4])Most pseudogenes, including SEPTIN14P21, have *no well-characterized biological function*.
04

Disease associations

Typically none (Some pseudogenes are deregulated in cancer or may modulate gene regulation in disease contexts, but there is no evidence or documentation for SEPTIN14P21 specifically[1][4])
05

Safety considerations

None (No therapeutic targeting or safety issues, as it is not an active or actionable biological molecule[3][4])
06

Interacting drugs

None (No known drugs interact with this pseudogene, because it does not encode a functional protein or receptor[3][4])
07

Biomarkers

None (Not known or reported as a biomarker for patient selection or efficacy monitoring[3][4])

Beyond the preview

Go deeper on Septin 14 pseudogene 21 (SEPTIN14P21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Septin 14 pseudogene 21 (SEPTIN14P21).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call